MERIT MEDICAL SYSTEMS INC
For the period ended Mar 31, 2025. Filed Apr 24, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 24, 2025
MMSI$87.81-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Common Stock · · Retained · · Accumulated Other · · · | ||||||||||||||
| · Shares · Amount · Earnings · Comprehensive Loss · Total | ||||||||||||||
| | | | | | | | | | | | | | | |
| Balance — January 1, 2025 | 58,743 | | $703,219 | | $695,541 | | $(19,401) | | $1,379,359 | |||||
| Net income | | | 30,147 | | | 30,147 | ||||||||
| Other comprehensive income | | | | 4,025 | | 4,025 | ||||||||
| Stock-based compensation expense | | 7,885 | | | | 7,885 | ||||||||
| Options exercised | 281 | | 14,610 | | | | 14,610 | |||||||
| Issuance of common stock under Employee Stock Purchase Plan | 4 | | 424 | | | | 424 | |||||||
| Shares issued from time-vested restricted stock units | | 130 | | | — | | | | | | | | | — |
| Shares surrendered in exchange for payment of payroll tax liabilities | (62) | | | (6,145) | | | | | | | | | (6,145) | |
| Shares surrendered in exchange for exercise of stock options | (18) | | (1,882) | | | | | | | | | (1,882) | ||
| Balance — March 31, 2025 | 59,078 | | $718,111 | | $725,688 | | $(15,376) | | $1,428,423 | |||||
| | |
|---|
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Common Stock · · Retained · · Accumulated Other · · · | ||||||||||||||
| · Shares · Amount · Earnings · Comprehensive Loss · Total | ||||||||||||||
| Balance — January 1, 2024 | 57,858 | | $638,150 | | $575,184 | | $(11,334) | | $1,202,000 | |||||
| Net income | | | 28,240 | | | 28,240 | ||||||||
| Other comprehensive loss | | | | | | | (1,122) | | (1,122) | |||||
| Stock-based compensation expense | | | 4,934 | | | | | | 4,934 | |||||
| Options exercised | 213 | | 7,394 | | | | | | 7,394 | |||||
| Issuance of common stock under Employee Stock Purchase Plan | 5 | | 336 | | | | | | 336 | |||||
| Shares issued from time-vested restricted stock units | | 47 | | | — | | | | | | | | | — |
| Shares surrendered in exchange for payment of payroll tax liabilities | (21) | | (1,592) | | | | | | | | | (1,592) | ||
| Balance — March 31, 2024 | 58,102 | | $649,222 | | $603,424 | | $(12,456) | | $1,240,190 | |||||
| | |
|---|---|
| See condensed notes to consolidated financial statements. | |
| | |
| | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.